July 9, 2003
National Pharmpak Has Recalled
The Food and Drug Administration (FDA) released the following information.
Premarin Tablets (conjugated estrogens tablets, USP), 1.25 mg, 100 and 1000
tablet bottles, Rx only. Recall # D-279-3.
Lots: #9000073B (100s) and #9000073W (1000s). Exp. Date on both lots is
National Pharmpak Services, Inc., Zanesville, OH, by letters dated February
Manufacturer: Ayerst Laboratories, Inc., A Wyeth-Ayerst Company,
Philadelphia, PA. Firm initiated recall is ongoing.
Dissolution failure by manufacturer (Wyeth)
VOLUME OF PRODUCT IN COMMERCE